Trials / Conditions / Renal Cell Carcinoma Recurrent
Renal Cell Carcinoma Recurrent
3 registered clinical trials studyying Renal Cell Carcinoma Recurrent.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cel NCT03634540 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Active Not Recruiting | A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) NCT02974738 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 |
| Unknown | Study of the Combination of CM082 With Everolimus in Patients With mRCC NCT02577458 | AnewPharma | Phase 1 |